Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Current Drug Development Market for Cytokines, Chemokines and Growth Factors' returned 19 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Drug Delivery in Cancer - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 639 Transcriptional targeting for cancer gene therapy Targeted epidermal growth factor-mediated DNA delivery Gene-based targeted drug delivery to tumors Targeting gene expression to hypoxic tumor cells Targeting Immune Modulation Therapeutics   Greystone Associates, Aug 2008, Pages: 85 Therapeutics – Disease Sector Analysis - Autoimmune Diseases - Infectious Diseases - Hereditary Diseases - Oncology - Metabolic Diseases Development-Stage Immune Factor Drug Candidates - TNF - Growth Factor Asthma: Modern Therapeutic Targets   Clinical Publishing, Jan 2007, Pages: 220 of a number of new therapies for asthma under exploration and development. A group of distinguished international authors examine the potential of new agents working on various targets that are currently under Biomarkers - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 864 and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker. Currently the most important applications of biomarkers are in drug discovery Antibody Drug Target Atlas in Oncology   Bioseeker, June 2007, Pages: 172 .8 Cytokine Activity Targets 6.9 DNA Topoisomerase Activity Targets 6.10 Extracellular Matrix Structural Constituent Targets 6.11 G-protein Coupled Receptor Activity Targets 6.12 Growth Factor Activity Pain Therapeutics - Drugs, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 532 brain barrier Drug delivery systems in clinical trials 6. Drug Development for Pain Introduction Drugs in development for pain Current research goals The ideal analgesic Pain R & D goals Cell Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 1008 of transduced HSCs in vivo Expansion of stem cells in vivo by Notch receptor ligands Mobilization of HSCs by growth factors Mobilization of stem cells by cytokines/chemokines Mobilization of adult human HSCs Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis   Bioseeker, Aug 2008, Pages: 316 This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. The author has identified three Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis   Bioseeker, Sep 2008, Pages: 306 This report aims to analyze the current and future potential of prostate cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. The author has identified three The Emerging Drug Targets Outlook: An Analysis of Novel Molecular Targets To Develop Innovative New Therapeutics   Business Insights, Nov 2005 receptors Implications for drug discovery Chapter 1 The drug target landscape Summary Introduction Description and comparison of drug targets Introduction Cytokines and chemokines G protein-coupled A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market   Bioseeker, June 2010, Pages: 838 This report comprises defined and up to date development strategies for 346 prostate cancer drugs within the portfolio of 198 investigators, from Ceased to Marketed. The report extensively analyses Antibody Drug Target Atlas in Oncology - Where to Commercialize in a Crowded Market Place?   Bioseeker, March 2010, Pages: 1289 Antibody Target Strategies in Cancer Currently in Phase III Clinical Development Table 20: The Competition Through Close Mechanistic Approximation Between Phase III Antibody Drugs in Oncology Table 21: New Competitor Analysis: FGF-R Agonists and Antagonists   La Merie, Nov 2009, Pages: 37 process is executed and regulated by an equally complex signaling network involving numerous growth factors, cytokines and chemokines. Of particular importance is the epidermal growth factor (EGF) family Antibody Drug Targets and Focus on Breast & Prostate Cancer   Bioseeker, Nov 2007, Pages: 380 and competitors. There are currently more than 400 antibody based drugs in development for the treatment of cancer. We have surveyed these antibodies and identified 132 antibody drug targets, belonging to 220 Antibody Drug Targets and Special Focus on Leukemias & Lymphomas   Bioseeker, Dec 2007, Pages: 430 and competitors. There are currently more than 400 antibody based drugs in development for the treatment of cancer. We surveyed these antibodies and identified 132 antibody drug targets, belonging to 220 antibody Gene Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 659 Complex (MHC) Class I IGF (Insulin-Like Growth Factor) Inhibition of immunosuppressive function in cancer Delivery of toxic genes to tumor cells for eradication Gene-directed enzyme prodrug therapy Respiratory Therapeutics and Devices Markets   TriMark Publications, May 2011, Pages: 158 .20: Current Respiratory Treatment for Cystic Fibrosis 62 Table 2.21: Key Novel Cystic Fibrosis Therapeutics 62 Table 2.22: Drug Development Pipeline Funded by the Cystic Fibrosis Foundation 63 Table 4.1: Common Rheumatoid arthritis: Emerging drug discovery targets and therapeutic candidates   Lead Discovery, Oct 2003 Table 13. Anti-Angiogenic Agents Targets for novel anti-angiogenic molecules Growth Factors Cytokines Chemokines Matrix Metalloproteases Plasminogen activators Asthma Therapeutics: New Treatment Options and Emerging Drug Discovery Targets   Lead Discovery, April 2003 therapeutics market and current pharmaceutical development activity. It has proved to be very difficult to develop new classes of anti-asthma therapy, partly because existing drugs, especially inhaled Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network